Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy

被引:11
|
作者
Hung, Tsung-Min [1 ,2 ]
Chen, Chien-Cheng [2 ,3 ]
Lin, Chien-Yu [1 ,2 ]
Ng, Shu-Hang [2 ,3 ]
Kang, Chung-Jan [2 ,4 ]
Huang, Shiang-Fu [2 ,4 ]
Liao, Chun-Ta [2 ,4 ]
Fan, Kang-Hsing [1 ,2 ]
Wang, Hung-Ming [2 ,5 ]
Chang, Joseph Tung-Chieh [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan
关键词
Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Prognosis; Prepontine cistern invasion; Distant metastasis; Intracranial extension; Head and neck cancer; BARR-VIRUS DNA; PHASE-II TRIAL; F-18-FDG PET; EXPERIENCE; CHEMOTHERAPY; CANCER;
D O I
10.1016/j.oraloncology.2013.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate the prognostic value of prepontine cistern invasion (PPCI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Materials and methods: Five hundred and four non-disseminated NPC patients who underwent magnetic resonance imaging examination before radical IMRT between November 2000 and December 2008 were retrospectively reviewed. The diagnostic criteria for PPCI were tumor invasion through the posterior cortex of clivus and extension into the prepontine cistern. Results: The median follow-up of the patients in this study was 63.5 months. PPCI was found in 44 patients (25% of T4 patients). The 5-year progression-free survival (PFS), local control (LC), distant metastasis- free survival (DMFS), and overall survival (OS) of all patients, with and without PPCI, were 44.3% and 70.5% (p < 0.001), 84.4% and 89.1% (p = 0.376), 66.6% and 87.3% (p < 0.001), and 59.6% and 80.2% (p < 0.001), respectively. In T4 patients with PPCI and without PPCI, the 5-year PFS, LC, DMFS, and OS were 44.3% and 62.5% (p = 0.023), 84.4% and 84.9% (p = 0.946), 66.6% and 83.1% (p = 0.022), and 59.6% and 71.0% (p = 0.045), respectively. Using multivariate analysis, PPCI was found to be an independent poor prognostic factor for PFS (HR = 1.816; p = 0.007), DMFS (HR = 1.928; p = 0.045), and OS (HR = 1.798; p = 0.016). Conclusion: Prepontine cistern invasion was an independent prognostic factor for poor DMFS and OS but not LC in NPC patients treated with IMRT, even within T4 patients. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [21] Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy
    Zeng, Lei
    Guo, Pi
    Li, Jin-Gao
    Han, Fei
    Li, Qiang
    Lu, Yong
    Deng, Xiao-Wu
    Zhang, Qing-Ying
    Lu, Tai-Xiang
    ONCOTARGET, 2015, 6 (36) : 39373 - 39383
  • [22] Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy
    Tang, Ling-Long
    Guo, Rui
    Zhou, Guanqun
    Sun, Ying
    Liu, Li-Zhi
    Lin, Ai-Hua
    Mai, Haiqiang
    Shao, Jianyong
    Li, Li
    Ma, Jun
    PLOS ONE, 2014, 9 (10):
  • [23] Reirradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy
    Chua, DTT
    Sham, JST
    Leung, LHT
    Au, GKH
    RADIOTHERAPY AND ONCOLOGY, 2005, 77 (03) : 290 - 294
  • [24] Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Wei Lu Kuang
    Qin Zhou
    Liang Fang Shen
    Clinical and Translational Oncology, 2012, 14 : 783 - 790
  • [25] Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Kuang, Wei Lu
    Zhou, Qin
    Shen, Liang Fang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10): : 783 - 790
  • [26] Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
    Tao, Chang-Juan
    Liu, Xu
    Tang, Ling-Long
    Mao, Yan-Ping
    Chen, Lei
    Li, Wen-Fei
    Yu, Xiao-Li
    Liu, Li-Zhi
    Zhang, Rong
    Lin, Ai-Hua
    Ma, Jun
    Sun, Ying
    CHINESE JOURNAL OF CANCER, 2013, 32 (09) : 494 - 501
  • [27] Clinical outcomes and prognostic factors of 582 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Lang, Jin Yi
    Wang, Weidong
    Xu, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
    ChangJuan Tao
    Xu Liu
    LingLong Tang
    YanPing Mao
    Lei Chen
    WenFei Li
    XiaoLi Yu
    LiZhi Liu
    Rong Zhang
    AiHua Lin
    Jun Ma
    Ying Sun
    Chinese Journal of Cancer, 2013, 32 (09) : 494 - 501
  • [29] Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era
    Zheng, Shuo-Han
    Zhou, Shu
    Wang, Guan-Nan
    Huang, Zi-Lu
    Liu, Song-Ran
    Chen, Chen
    Tao, Ya-Lan
    Chang, Hui
    Ding, Shi-Rong
    Liao, Ruo-Nan
    Chen, Chang
    Xia, Yun-Fei
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (11) : 4624 - 4635
  • [30] Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    Yuan Zhang
    Wen-Fei Li
    Lei Chen
    Yan-Ping Mao
    Rui Guo
    Fan Zhang
    Hao Peng
    Li-Zhi Liu
    Li Li
    Qing Liu
    Jun Ma
    Scientific Reports, 5